47 related articles for article (PubMed ID: 19708567)
1. [Results of the treatment of adult acute lymphoblastic leukemia according to ALL-2005 protocol as a basis for new trials].
Parovichnikova EN; Davidian IuR; Isaev VG; Sokolov AN; Kliasova GA; Mendeleeva LP; Liubimova LS; Ustinova EN; Gribanova EO; Mavrina ES; Kulikov SM; Kaplanov KD; Zagoskina TP; Sviridova EI; Gavrilova LV; Savchenko VG
Ter Arkh; 2009; 81(7):8-15. PubMed ID: 19708567
[TBL] [Abstract][Full Text] [Related]
2. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
[TBL] [Abstract][Full Text] [Related]
3. [First results of Ph-negative acute lymphoblastic leukemia therapy of adults according to the protocol of Research Group of Russian Hematological Centers ALL-2009].
Parovichnikova EN; Kliasova GA; Isaev VG; Sokolov AN; Kokhno AV; Troitskaia VV; Mavrina EV; Khodunova EE; Ustinova EN; Gribanova EO; Kravchenko SK; Ryzhko VV; Kaporskaia TS; Baranova OIu; Bondarenkko SN; Nizametdinova AS; Kondakova EV; Ryl'tsova TV; Alufer'eva AN; Samoĭlova OS; Skamorina OP; Gavrilova LV; Pristupa AS; Vopilina NA; Konstantinova TS; Kriuchkova IV; Anchukova LV; Tikunova TS; Kaplanov KD; Lapin VA; Tumakov VA; Kozmina MN; Chernysh SA; Podol'tseva EI; Kulikov SM; Davidian IuR; Savchenko VG
Ter Arkh; 2011; 83(7):11-7. PubMed ID: 21894746
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of adult acute lymphoblastic leukemia according to GMALL 07/2003 study protocol in the Czech Republic - the first experience].
Folber F; Sálek C; Doubek M; Soukupová Maaloufová J; Valová T; Trka J; Gökbuget N; Vydra J; Kozák T; Horácek JM; Zák P; Cetkovský P; Hoelzer D; Mayer J
Vnitr Lek; 2010 Mar; 56(3):176-82. PubMed ID: 20394203
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.
Ribera JM; Oriol A; Bethencourt C; Parody R; Hernández-Rivas JM; Moreno MJ; del Potro E; Torm M; Rivas C; Besalduch J; Sanz MA; Ortega JJ;
Haematologica; 2005 Oct; 90(10):1346-56. PubMed ID: 16219571
[TBL] [Abstract][Full Text] [Related]
6. Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients.
Ho CL; Chen YC; Kao WY; Chao TY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):45-52. PubMed ID: 10645050
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
[TBL] [Abstract][Full Text] [Related]
8. Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen.
Storring JM; Minden MD; Kao S; Gupta V; Schuh AC; Schimmer AD; Yee KW; Kamel-Reid S; Chang H; Lipton JH; Messner HA; Xu W; Brandwein JM
Br J Haematol; 2009 Jun; 146(1):76-85. PubMed ID: 19438471
[TBL] [Abstract][Full Text] [Related]
9. [Superhigh doses of dexamethasone in treatment of refractory forms of acute lymphoblast leukemia of adults].
Parovichnikova EN; Savchenko VG; Isaev VG; Sokolov AN; Moskov VI; Kliasova GA; Gal'tseva IV; Ustinova EN; Gribanova EO; Lapin VA
Ter Arkh; 2003; 75(7):21-3. PubMed ID: 12934476
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.
Pession A; Valsecchi MG; Masera G; Kamps WA; Magyarosy E; Rizzari C; van Wering ER; Lo Nigro L; van der Does A; Locatelli F; Basso G; Aricò M
J Clin Oncol; 2005 Oct; 23(28):7161-7. PubMed ID: 16192600
[TBL] [Abstract][Full Text] [Related]
11. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
[TBL] [Abstract][Full Text] [Related]
12. Long-term results in non randomized patients with acute myelogenous leukemia: a single institution experience.
Deliliers GL; Annaloro C; Oriani A; Della Volpe A; Boschetti C; Cortelezzi A; Maiolo AT
Ann Ital Med Int; 1998; 13(3):146-51. PubMed ID: 9859570
[TBL] [Abstract][Full Text] [Related]
13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
14. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
Hunault M; Truchan-Graczyk M; Caillot D; Harousseau JL; Bologna S; Himberlin C; Guyotat D; Berthou C; Casassus P; Baranger L; Béné MC; Ifrah N; Gyan E;
Haematologica; 2007 Dec; 92(12):1623-30. PubMed ID: 18055985
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of 71 adult acute lymphoblastic leukemia].
Yoshida M; Kurata H; Tsunoda S; Iwama A; Suzuki T; Akutsu M; Imagawa S; Tsunoda J; Furukawa Y; Komatsu N
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1827-33. PubMed ID: 8379676
[TBL] [Abstract][Full Text] [Related]
16. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Qin J; Wollner N
Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of acute lymphatic leukemia in adults: pilot project with intensive early therapy without a maintenance phase].
Wernli M; Gratwohl A; von Fliedner V; Tichelli A; Clément F; Grob JP; Chapuis B; Maurice P; Brun del Re G; Fey MF
Schweiz Med Wochenschr; 1991 Feb; 121(6):194-8. PubMed ID: 2008599
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of adult acute lymphoblastic leukemia by KHALL-93--long-term outcome].
Usuki K; Adachi Y; Kazama K; Iki S; Urabe A
Gan To Kagaku Ryoho; 2000 Aug; 27(9):1397-402. PubMed ID: 10969595
[TBL] [Abstract][Full Text] [Related]
20. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol.
Bajel A; George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
Pediatr Blood Cancer; 2008 Nov; 51(5):621-5. PubMed ID: 18688848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]